Current Chemotherapy Options in the Treatment of Malignant Gliomas of the Central Nervous System in Children
Authors:
J. Štěrba; Z. Pavelka; J. Skotáková; T. Kepák
Authors‘ workplace:
Oddělení dětské onkologie, FN Brno - Dětská nemocnice, primář MUDr. J. Štěrba, PhD. Klinika dětské radiodiagnostiky, FN Brno - Dětská nemocnice, přednosta doc. MUDr. J. Procházka, CSc. Univerzitní onkologické centrum, Brno, programovaný vedoucí doc. MUDr.
Published in:
Čes-slov Pediat 2001; (9): 537-542.
Category:
Overview
Children with high-grade gliomas have still a very poor prognosis, despite the improvement of diagnostic and therapautic approaches. Looking for new therapeutic options may improve the prospects of these children.The authors summarize the results and contribution of the current therapeutic modalities (neurosurgical approach, XRT and chemotherapy) and present a modern therapeutic pattern for children with high-risk glial tumours of the central nervous system using concomitant chemoradiotherapy (XRT and temozolomide) and anti-angiogenic treatment with thalidomide.
Key words:
malignant gliomas of the central nervous system, concomitant chemoradiotherapy, temozolomide, thalidomide
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
2001 Issue 9
Most read in this issue
- Respiratory Failure as a Result of ARDS as a High Risk Complication of Treatment of Acute Leukaemia and Myelodysplastic Syndrome in Children
- Hyperhomocysteinaemia in Children with Chronic Renal Insufficiency
- Double Trisomy (+13,+15) in Spontaneous Abortion
- Diagnosis of Obstruction of the Pyeloureteral Junction: Comparison of Results of Dynamic